Sana Biotechnology Inc vs Trade Desk Inc — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Trade Desk Inc trades at $18.25 (market cap $8.76B). The key difference: Trade Desk Inc is far larger — about 10× Sana Biotechnology Inc's market cap, and Sana Biotechnology Inc is trading nearer its 52-week high, Trade Desk Inc nearer its low. Which is the better fit depends on your goals.
| SANA | TTD | |
|---|---|---|
Market Cap | $873.84M | $8.76B |
Sector | Health | Technology |
52-Week High | $5.92 | $89.76 |
52-Week Low | $2.68 | $17.33 |
Enterprise Value | $848.03M | $7.78B |
Trailing returns across standard periods
Latest headlines on both assets
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →The Trade Desk Inc is engaged in providing a technology platform for ad buyers. Through its cloud-based platform ad buyers can create, manage, and optimize data-driven digital advertising campaigns across ad formats and channels, including display, video, audio, in-app, native and social, on a multitude of devices. Its products include Data Management Platform, Cross-Device Targeting, Video Advertising, Mobile Advertising, and others.
Read more on TTD →